AlphaYouMP
Insider selling
Matthew Pauls sold $21K of Pelthos Therapeutics Inc. (PTHS) stock
Matthew Pauls, Dir of Pelthos Therapeutics Inc. (PTHS), sold 786 shares of PTHS stock worth $21K, per an SEC Form 4 filed Jul 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 2, 2026, 5 days before it was made public.
PTHS has moved -10.2% since the trade date, from $25.77 to $23.15 (Sep 21, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filing delay
- 5 days
- Price since
- -10.2%
- Role
- Dir
- Source
- SEC Form 4
More PTHS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.